SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-23-000085
Filing Date
2023-06-15
Accepted
2023-06-15 16:43:47
Documents
15
Period of Report
2023-06-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20230609.htm   iXBRL 8-K 121059
2 EX-3.1 a20230608formx7thamendedan.htm EX-3.1 296952
3 EX-99.1 a20230608formxeha2023press.htm EX-99.1 34541
4 EX-99.2 a20230615formxicmlpressrel.htm EX-99.2 35190
  Complete submission text file 0001651308-23-000085.txt   703403

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20230609.xsd EX-101.SCH 1901
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20230609_lab.xml EX-101.LAB 24751
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20230609_pre.xml EX-101.PRE 13019
9 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20230609_htm.xml XML 11563
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 231018023
SIC: 2834 Pharmaceutical Preparations